Related Experiment Video
Updated: Apr 26, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Does interval between screening and baseline matter in HD cognitive clinical trials?
Leigh J Beglinger1, William H Adams2, Douglas Langbehn3
1University of Iowa, Iowa City, IA, USA Elks Rehab Hospital, Boise, ID, USA.
Practice effects (PE) in cognitive testing can skew results. This study found that the time between tests and Huntington Disease severity impact PE in cognitive assessments for clinical trials.
Area of Science:
- Neuroscience
- Clinical Trials
- Cognitive Assessment
Background:
- Practice effects (PE) are performance improvements from repeated testing.
- PE can confound cognitive test results, especially with short retest intervals.
Purpose of the Study:
- To investigate how retest interval length influences practice effects in cognitive tests.
- To examine these effects in individuals with mild Huntington Disease (HD).
Main Methods:
- Study involved 34 adults with mild HD undergoing cognitive tests.
- Two groups were formed: one with a 24-hour retest interval, another with >6-day interval.
- Cognitive tests were administered at screening and baseline before treatment randomization.
Main Results:
- Practice effects varied between groups on specific UHDRS cognitive tests after controlling for age and motor scores.
- Longer intervals showed greater PE on Symbol-Digit Modalities and Stroop color.
- Shorter intervals showed greater PE on Stroop interference.
Conclusions:
- Retest interval length and HD severity may affect the stability of UHDRS cognitive test results.
- Findings are crucial for interpreting cognitive data in HD clinical trials.
- Consideration of these factors is essential for robust trial design.
More Related Videos
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019